The name we give a condition quietly decides how we treat it. For this one, the usual name points in the wrong direction.
You have almost certainly heard of PCOS (Polycystic Ovary Syndrome) or PCOD. At Kyros, we also call it PMOS — Poly-Metabolic Ovarian Syndrome. Same condition, clearer name. The change is not cosmetic: it moves the focus from the ovaries to the metabolism, which is where the real story usually begins. Here is what that means, and why it matters especially for Indian women.
First, the honest footing: PCOS and PCOD are the medically recognised terms, and you will still see them everywhere — including in this article, so it stays easy to find and follow. PMOS is the way we frame the condition to keep the real driver in view. It is about emphasis, not a different disease.
What's wrong with the name "PCOS"?
The "PCOS" name centres one thing: "polycystic ovaries" — the appearance of many small follicles on a scan. Many doctors and patient advocates have long argued this name is misleading, for good reasons:
- Those "cysts" are not true cysts — they are normal follicles. The word frightens women unnecessarily.
- Many women with the condition don't have that ovarian appearance at all — yet still have the hormone and metabolic problem.
- It points attention at the ovaries, when the engine underneath is often insulin and metabolism.
In other words, the common name describes a finding on a scan rather than the cause of the problem. There have been genuine international calls over the years to rename it for exactly this reason.
What PMOS puts in the centre
PMOS keeps the metabolic driver in the name. Across the Kyros library you'll see the same theme again and again: the weight gain, the irregular cycles, the skin and hair changes are frequently powered by insulin resistance — a metabolic problem. Naming the condition for its metabolism does three useful things:
- It tells women the issue is not just "ovary cysts" to be scanned and dismissed.
- It explains why weight, insulin, and diet matter so much in care.
- It connects the condition to its real long-term risks — including type 2 diabetes.
The name becomes a map to the treatment, instead of a misleading label.
Why this matters especially for India
This is the part that makes PMOS more than a wording choice. Indian women carry unusually high metabolic and insulin-resistance risk — it shows up at lower weights and earlier ages than in many other populations. The condition is common here: an ICMR national study found it in close to 1 in 5 women by wider criteria (Ganie et al., JAMA Network Open, 2024).
When the condition is framed only as an "ovary" problem, the metabolic side gets ignored — and that is the side that quietly drives diabetes and heart risk in Indian women. Framing it as metabolic from the start pushes earlier, better care: checking insulin and blood sugar, taking weight seriously, and protecting long-term health — not just looking at a scan and moving on. For Indian women, that shift in emphasis is not academic. It changes what gets caught, and when.
And PCOS vs PCOD — where do they fit?
Quickly, since people ask: PCOD usually describes the ovaries (many follicles), while PCOS is the wider hormone-and-metabolic condition, generally seen as more significant. The terms are used loosely, even by labs. PMOS simply makes the point that, for both, the deeper driver is often metabolic — which is exactly what tends to get missed.
A better name doesn't change the condition. It changes whether we treat the part that actually matters.
Talk to a doctor
Whatever name you've been given — PCOS, PCOD, or PMOS — an NMC-registered doctor on Kyros can look at the metabolic picture properly. Take the assessment.
References
- Ganie MA, et al. Prevalence and clinical features of PCOS in India (ICMR national study). JAMA Network Open, 2024.
Medically reviewed by [doctor name, NMC reg. no.] on [date]. For general information only; not a substitute for your own doctor. PCOS/PCOD remain the medically recognised terms for this condition.